Upgrade to SI Premium - Free Trial

Argus Upgrades Novartis (NVS) to Buy

March 11, 2026 7:34 AM
Argus analyst Jasper Hellweg upgraded Novartis (NYSE: NVS) from Hold to Buy with a price target of $180.00.The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Upgrades